Vmbook Online ordering

Icons

**Company Overview**

**Name:** Icon Plc

**Stock Symbol:** PEN (NYSE)

**Industry:** Contract Research Organization (CRO)

**Pen Fill**

Pen Fill is a service offered by Icon that provides clinical trial supplies to patients. This includes the packaging, labeling, and distribution of study drugs and other materials. Pen Fill plays a critical role in ensuring the accuracy and safety of clinical trials.

**Financial Performance**

**Earnings:**

* Revenue in 2022: $5.3 billion

* Net income in 2022: $500 million

* Diluted EPS in 2022: $2.15

**Growth:**

* Revenue growth in 2022: 12%

* Net income growth in 2022: 15%

* Diluted EPS growth in 2022: 17%

**Key Metrics:**

* Backlog: $13.5 billion as of December 2022

* Number of employees: 20,000+

* Global presence: Operations in over 50 countries

**Strengths:**

* Leading global CRO with a strong reputation

* Comprehensive suite of clinical trial services

* Expertise in Pen Fill and other specialized areas

* Strong financial performance and growth prospects

**Weaknesses:**

* Competition from other large CROs

* Dependence on the pharmaceutical industry

* Potential for regulatory changes that could impact the CRO industry

**Outlook:**

Icon expects continued growth in the future driven by:

* Increasing demand for clinical trials

* Expansion into new therapeutic areas

* Continued investment in Pen Fill and other services